Aligos Therapeutics (5WK0.F) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.63
-2.19
-1.75
-1.31

Details

Expected EPS
-1.8871821095399999
Actual EPS
-1.8844007
Surprise EPS
0
Surprise Percent
+0.15%

Description

⁨Aligos Therapeutics⁩ (⁦5WK0.F⁩) has reported earnings of ⁦-1.8844007⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts